AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: net buying of $1K to $15K in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- +$1K to +$15K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $290.13
- 52-wk high
- $392.70
- High
- $298.56
- 52-wk low
- $50.31
- Low
- $286.00
- Prev close
- $286.91
- Mkt cap
- $8.25B
- Volume
- 456.1K
- Beta
- 2.78
- P/S
- 144.7x
- P/B
- 5.9x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -38.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PRAX filings
Are insiders buying or selling Praxis Precision Medicines Inc (PRAX) stock?
Neither. Praxis Precision Medicines Inc (PRAX) insiders filed no open-market purchases or sales in the 90 days to Oct 5, 2026, according to SEC Form 4 filings.
Which members of Congress have traded PRAX recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Jul 30, 2026, disclosed 36 days later. In total, 1 member disclosed 1 PRAX trade with trade dates in the last 180 days, filed a median 36 days after trading.
How current is this PRAX smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- MW
Marshall Wace
$31.3M
added
- FM
FMR LLC
$295.8M
added
Sells/Trims (1)
- P7
Point72
$145.1M
sold
What insiders are doing
Sells (1)
- DJ
Desimone Jill
$3.6M
sold
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in PRAX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 20.3% above what analysts expected.
Last report
Aug 3, 2026
Period ending
Jun 30, 2026
Earnings per share
-$3.60 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 3, 2026 | -$2.87 / -$3.60Alpha Vantage | +20.28% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$3.20 / -$3.68Alpha Vantage | +13.04% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 19, 2026 | -$3.50 / -$3.13Alpha Vantage | -11.82% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | -$3.36 / -$3.45Alpha Vantage | +2.61% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 4, 2025 | -$3.31 / -$3.36Alpha Vantage | +1.49% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 2, 2025 | -$3.29 / -$3.21Alpha Vantage | -2.49% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 28, 2025 | -$2.94 / -$2.82Alpha Vantage | -4.29% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 6, 2024 | -$2.75 / -$1.95Alpha Vantage | -41.03% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 4, 2026, in 30 days
Estimates as of Oct 5, 2026
EPS expected
-$5.60 to -$2.74
Last 30 days
Analysts raising estimates
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $8.3B
Valuation
- P/S144.69
- P/B5.88
Quality
- Operating margin0.0%
- ROE-38.9%
- ROA-25.7%
Growth
- Beta2.78
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace